1 year return (CAGR)
59.35%
Protara Therapeutics Inc Exchange (NASDAQ, USD)
TARA
3.82
-0.29 (-5.12%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
19.46%
5 year return (CAGR)
-13.66%
10 year return (CAGR)
-34.83%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
295.67M
Price/Sales
-
Ent value
259.07M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.66 |
| Daily high | 5.68 |
| Daily low | 5.32 |
| Daily Volume | 439K |
| All-time high | 800.00 |
| 1y analyst estimate | 25.71 |
| Beta | 1.49 |
| EPS (TTM) | -1.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TARA | S&P500 | |
| Current price drop from All-time high | -99.52% | -1.75% |
| Highest price drop | -99.86% | -56.47% |
| Date of highest drop | 22 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -84.97% | -10.69% |
| Avg time to new high | 100 days | 12 days |
| Max time to new high | 2718 days | 1805 days |
News
